Solarvest bags solar PV contract for Dexcom facility in Batu Kawan

KUALA LUMPUR: Solarvest Holdings Bhd has secured a contract from Dexcom Malaysia Sdn Bhd to install a 3.6 megawatt-peak (MWp) solar photovoltaic (PV) system at its manufacturing facility in Batu Kawan, Penang.

The manufacturing facility in Batu Kawan will be the first overseas facility of Dexcom's US parent, Dexcom Inc, an industry-leading provider of continuous glucose monitoring systems

In a statement, Solarvest said it will serve as the engineering, procurement, construction, and commission (EPCC) provider for the installation of rooftop solar PV for the main building facilities and carpark.

With the expected generation of 3.6MWp of clean energy, it said Dexcom will offset 3,190 tonnes of carbon dioxide.

According to Solarvest executive director and group CEO Davis Chun Shiong, the facility is expected towards Dexcom's overseas expansion ESG initiatives while optimising operational cost.

"The growing recognition of sustainability’s significance in business operations has led to a surge in the adoption of clean energy by corporates.

"As a result, our job pipeline remains strong, with a tender book of approximately 2.5 gigawatts (GW) across Malaysia, Taiwan, Philippines, Vietnam, Indonesia, Singapore, and Thailand," he said.

He added that the company has plans to boost its current unbilled order book of RM550mil by leveraging on the release of the 800MW solar PV assets quota under the corporate green power programme.